Genomind Supports New Reimbursement Initiatives and Patient Access to Mental Health Pharmacogenomic Tests with PGx Report Focused on Anxiety and Depression
New CORE Depression and Anxiety Report follows UnitedHealthcare’s positive coverage decision for Genomind Professional PGx Express for certain patients.
